(Q30638020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Factors influencing haemorrhagic transformation in ischaemic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Olga Maisterra

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Estevo Santamarina

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Carlos S Kase

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

31 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

689-705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

cites work

Hemorrhagic infarcts.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Triggers and mediators of hemorrhagic transformation in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Is asymptomatic hemorrhagic transformation really innocuous?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Is asymptomatic hemorrhagic transformation really innocuous?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic cerebral infarction--a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Sequential computerized tomographic appearance of strokes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation in cerebral embolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis of 55 Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Stroke severity in atrial fibrillation. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation of ischemic stroke: severe complications of prosthetic valve endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Admission CT perfusion is an independent predictor of hemorrhagic transformation in acute stroke with similar accuracy to DWI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

T2*-weighted imaging enables excellent interobserver concordance but should not be considered as sole gold standard imaging for hemorrhagic transformation classification after thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Postthrombolysis Blood Pressure Elevation Is Associated With Hemorrhagic Transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Early infarct FLAIR hyperintensity is associated with increased hemorrhagic transformation after thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Clinical importance of microbleeds in patients receiving IV thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Clinical applications of susceptibility weighted imaging in patients with major stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

How to design an opioid drug that causes reduced tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Timing of Spontaneous Recanalization and Risk of Hemorrhagic Transformation in Acute Cardioembolic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hemorrhage in the Interventional Management of Stroke study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Fever in acute stroke worsens prognosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Fibronectin at a glance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Serum S-100beta as a possible marker of blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Brain injury after intracerebral hemorrhage: the role of thrombin and iron.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Long-term effects of experimental intracerebral hemorrhage: the role of iron.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Pleiotropic functions of plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombin-activatable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Fibrin clot properties in acute ischemic stroke: relation to neurological deficit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Protein C anticoagulant and cytoprotective pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Factor XIII, clot structure, thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Emergent use of anticoagulation for treatment of patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Extension of the thrombolytic time window with minocycline in experimental stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970055-3

7 January 2021

10.1016/S1474-4422(13)70055-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726850%20AND%20SRC:MED&resulttype=core&format=json

release_psj3ixrggrairnv4zjvojqmfwy

2 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/psj3ixrggrairnv4zjvojqmfwy

24 November 2022

mapped directly with Wikidata item

1 reference